Tokyo University Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2017
NCT04274257
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Tokyo University